Showing results (821-830 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|July 3, 2019
Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 DiabetesMarine Halbron, Olivier Bourron, Fabrizio Andreelli, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Diabetic Ketoacidosis After Sodium-Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 DiabetesMargaretha M Visser, Chantal Mathieu, Pieter Gillard
Diabetes Technology & Therapeutics|June 7, 2019
Utilizing eHealth and Telemedicine Technologies to Enhance Access and Quality of Consultations: It's Not What You Say, It's the Way You Say ItKatharine Barnard-Kelly
Diabetes Technology & Therapeutics|October 16, 2019
Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor AgeMichael Tsoukas, Joanna Rutkowski, Anas El-Fathi, et al.
Diabetes Technology & Therapeutics|April 25, 2022
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.
Diabetes Technology & Therapeutics|October 27, 2021
Cost-Effectiveness of Low-Dose Antithymocyte Globulin Versus Other Immunotherapies for Treatment of New-Onset Type 1 DiabetesHai V Nguyen, Desmond A Schatz, Shweta Mital, et al.
Diabetes Technology & Therapeutics|October 27, 2021
With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose MonitoringRyan Bailey, Peter Calhoun, Christy Chao, et al.
Diabetes Technology & Therapeutics|October 27, 2021
Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different AgesXixi Nan, Xia Li, Yufei Xiang, et al.
Diabetes Technology & Therapeutics|March 29, 2022
Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P StudyRavinder Jeet Kaur, Byron H Smith, Basak Ozaslan, et al.
Diabetes Technology & Therapeutics|January 27, 2022
Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making ProcessShana R Mencher, Stuart A Weinzimer, Laura M Nally, et al.
Pageof 282